← Back to headlines
Intelligent Bio Solutions Clears Accuracy Milestone Ahead of FDA Submission
The biotech firm reports achieving over 98% accuracy in method comparison testing, positioning it to proceed with a planned 2026 FDA 510(k) regulatory submission for its diagnostic platform.
1 Sept, 12:31 — 1 Sept, 12:31
Related Stories
RFK Jr. Allegedly Requested Removal of Measles Deaths From CDC Tally
52m ago
Pentagon Temporarily Rescinds Mandatory Testosterone Screening Guidance for Troops
1h ago
Experts Warn Obsessive Sleep Tracking May Disrupt Rest Quality
2h ago
UNICEF Reports 20 Million Children Face Annual Online Sexual Abuse
2h ago